Diacerhein versus glucosamine in a rat model of osteoarthritis

Clinics

Volumn 61, Issue 5, 2006, Pages 461-466

  De Rezende, Márcia Uchôa ^a   Gurgel, Henrique Melo De Campos ^a   Vilaça Jr , Paulo Roberto ^a   Kuroba, Rogério Kawassaki ^a   Lopes, Alex Silva Santiago ^a   Phillipi, Renée Zon ^a   Hernandez, Arnaldo José ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anthraquinone; Glucosamine; Knee; Meniscectomy; Osteoarthritis; Rats

Indexed keywords

ANTHRAQUINONE DERIVATIVE; DIACETYLRHEIN; GLUCOSAMINE; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL; ARTICLE; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECT; HINDLIMB; HOSPITALIZATION; KNEE MENISCUS; KNEE OSTEOARTHRITIS; MALE; POSTOPERATIVE CARE; RAT; ULTRASTRUCTURE; WISTAR RAT;

ANIMALS; ANTHRAQUINONES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DISEASE MODELS, ANIMAL; GLUCOSAMINE; MALE; MENISCI, TIBIAL; OSTEOARTHRITIS, KNEE; POSTOPERATIVE CARE; RATS; RATS, WISTAR; SEVERITY OF ILLNESS INDEX; STIFLE;

EID: 33750408764     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Dougados M, Nguyen M, Berdah L, Mazières B, Vignon E, Lequesne M. Evaluation of the structure-modifying effects of diacerhein in hip osteoarthritis. Arthritis Rheum. 2001;44:2539-47.
2. Pavelká K, Gatterová J, Olejarová M, Machacek S, Giacovelli G, Rovati L. Glucosamine sulfate use and delay of progression of knee osteoarthritis. Arch Intern Med. 2002;162:2113-23.
3. Tamura T, Ohmori K. Rhein, an active metabolite of diacerhein, suppresses the interleukin-1 alpha-induced proteoglycan degradation in cultured rabbit articular chondrocytes. Japan J Pharmacol. 2001;85:101-4.
4. Armstrong S, Read R, Ghosh P. The effects of intraarticular hyaluronan on cartilage and subchondral bone changes in an ovine model of early osteoarthritis. J Rheumatol. 1994;21:680-8.
5. Hwa SY, Burkhardt D, Little C, Ghosh P. The effects of orally administered diacerhein on cartilage and subchondral bone in an ovine model of osteoarthritis. J Rheumatol. 2001;28:825-34.
6. Reijman M, Bierma-Zeinstra SM, Pols HA, Koes BW, Stricker BH, Hazes JM. Is there an association between the use of different types of nonsteroidal antiinflammatory drugs and radiologic progression of osteoarthritis? The Rotterdam Study. Arthritis Rheum. 2005;52:3137-42.
7. Setnikar I, Cereda R, Pacini M, Revel L. Antireactive properties of glucosamine sulfate. Drug Res. 1991;41:157-61.
8. Kay AG, Griffiths LG, Volans GN, Grahame R. Preliminary experience with diacetylrhein in the treatment of osteoarthritis. Curr Med Res Opin. 1980;6:548-51.
9. Mauviel A, Daireaux M, Hartman DJ, Galera P, Loyau G, Pujol JP. Effets des insaponifiables d'avocat et de soja (PIAS) sur la production de collagène par des cultures des synoviocytes, chondrocytes articulaires et fibroblastes dermiques. Rev Rhum Mal Osteoatic. 1989;56:207-11.
10. Rezende MU. Efeito do ácido hialurônico e da diacereína na artrose: modelo experimental em ratos [thesis]. São Paulo: Faculty of Medicine, University of Sao Paulo; 2002.
11. Towheed TE, Anastassiades TP, Shea B, Houpt J, Welch V, Hochberg MC. Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev. 2001;1:CD002946.
12. Müller-Fassbender H, Bach GL, Haase W, Rovati LC, Setnikar I. Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee. Osteoarthritis cartilage. 1994;2:61-9.
13. Reginster JY, Deroisy R, Rovati LC, Lee RL, Lejeune E, Bruyere O, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet. 2001;357:251-6.
14. Mazières B, Berdah L, Thiéchart M, Viguier G. Étude de la diacetylrhéine sur un modèle post-contusif d'arthrose expérimentale chez le lapin. Rev Rhum. 1993;60:77-81.
15. Mazières B, Blanckaert A, Thiéchart M, Viguier G. La diacerhéine administrée "curativement" dans un modèle expérimental d'arthrose post-contusive chez le lapin. Rev Prat. 1996;46:42-5.
16. Pelletier JP, Yaron M, Haraoui B, Cohen P, Nahir MA, Choquette D, et al. Efficacy and safety of diacerhein in osteoarthritis of the knee: a double-blind, placebo-controlled trial. The Diacerhein Study Group. Arthritis Rheum. 2000;43:2339-48.
17. Gouze JN, Bordji K, Gulberti, Terlain B, Netter P, Magdalou J, et al. Interleukin-1 â down-regulates the expression of glucuronosyltransferase I, a key enzyme priming glycosaminoglycan biosynthesis. Arthritis Rheum. 2001;44:351-60.
18. Piperno M, Reboul P, Le Graverand MPH, Peschard MJ, Annefeld M, Richard M, et al. Glucosamine sulfate modulates dysregulated activities of human osteoarthritic chondrocytes in vitro. Osteoarthritis Cartilage. 2000;8:207-12.
19. Rezende MU, Lopes ASS, Tsai AWW, Torres JL, Oliveira CRGCM, Bolliger Neto R, et al. Estudo do efeito condroprotetor da diacereína no modelo experimental de artrose em ratos. [in press]
20. Chan PS, Caron JP, Rosa GJ, Orth MW. Glucosamine and chondroitin sulfate regulate gene expression and synthesis of nitric oxide and prostaglandin E(2) in articular cartilage explants. Osteoarthritis Cartilage. 2005;13:387-94.
21. Nakamura H, Shibakawa A, Tanaka M, Kato T, Nishioka K. Effects of glucosamine hydrochloride on the production of prostaglandin E2, nitric oxide and metalloproteases by chondrocytes and synoviocytes in osteoarthritis. Clin Exp Rheumatol. 2004;22:2939.
22. Van Blitterswijk WJ, Van de Nes JCM, Wuisman PIJM. Glucosamine and chondroitin sulfate supplementation to treat symptomatic disc degeneration: biochemical rationale and case report. BMC Complement Altern Med. 2003;3:1-8.
23. McAlindon TE, LaValley MP, Gulin JP, Felson DT. Glucosamine and chondroitin for treatment of osteoarthritis. JAMA. 2000;283:1469-74.